Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes

Diabetes Care

Volumn 26, Issue 8, 2003, Pages 2400-2404

  Larsen, Jakob R ^a   Sjoholm, Hans ^a   Hanssen, Kristian F ^a,b   Sandvik, Leiv ^a   Berg, Tore J ^a,b   Dahl Jorgensen, Knut ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ACTION POTENTIAL; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; NERVE CONDUCTION; NERVE FUNCTION; NERVE POTENTIAL; PERIPHERAL NERVE; PREDICTION; PROSPECTIVE STUDY; TIBIAL NERVE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MOTOR NEURONS; NEURAL CONDUCTION; NEURONS, AFFERENT; PERONEAL NERVE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SURAL NERVE;

EID: 0042023728     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.8.2400     Document Type: Article

References (19)

1. Martyn CN, Hughes RA: Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 62:310-318, 1997
2. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Neurology 38:1161-1165, 1988
3. Claus D, Mustafa C, Vogel W, Herz M, Neundorfer B: Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve 16:757-768, 1993
4. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ III, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA: The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41:799-807, 1991
5. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
6. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 38:869-880, 1995
7. Boulton AJ, Knight G, Drury J, Ward JD: The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 8:125-128, 1985
8. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O: Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. BMJ 293:1195-1199, 1986
9. Amthor KF, Dahl-Jorgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, Hanssen KF: The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo study. Diabetologia 37:579-584, 1994
10. Dahl-Jorgensen K, Bjoro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF: Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 41:920-923, 1992
11. Falck B, Andreassen S, Groth T, Lang H, Melander M, Nurmi A, Rosenfalck A, Stalberg E, Suojanen M: The development of a multicenter database for reference values in clinical neurophysiology-principles and examples. Comput Methods Programs Biomed 34:145-162, 1991
12. Ziegler D, Behler M, Akila F: Near-normoglycaemia maintained over 14 years from the diagnosis of type 1 diabetes prevents the development of polyneuropathy (Abstract). Diabetologia 44 (Suppl. 1):A14, 2001
13. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
14. Hyllienmark L, Golster H, Samuelsson U, Ludvigsson J: Nerve conduction defects are retarded by tight metabolic control in type I diabetes. Muscle Nerve 24:240-246, 2001
15. Padua L, Saponara C, Ghirlanda G, Padua R, Aprile I, Caliandro P, Tonali P: Lower limb nerve impairment in diabetic patients: multiperspective assessment. Eur J Neurol 9:69-73, 2002
16. Tkac I, Bril V: Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 21:1749-1752, 1998
17. Boulton AJM, Malik RA: Diabetic neuropathy. Med Clin North Am 82:909-929, 1998
18. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA, Orchard TJ: Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456-1461, 1989
19. Forrest KYZ, Maser RE, Pambianco G, Becker DJ Orchard TJ: Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 46:665-670, 1997